Daniela Francesca Angelini

9PUBLICATIONS
59CO-AUTHORS
AutoimmunityMedical infection agents (incl. prions)Liquid biopsiesMetabolic medicineHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 18, 2026
From Marginal to Central: Marginal Zone-like B Cells as Critical Targets in Cladribine-Treated Multiple Sclerosis.

|Apr 04, 2025
A disease-specific convergence of host and Epstein-Barr virus genetics in multiple sclerosis.

Rosella Mechelli, Renato Umeton, Gianmarco Bellucci

|Aug 12, 2023
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.

Nelida Ines Noguera, Serena Travaglini, Stefania Scalea

|May 28, 2022
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment.

Cristina Banella, Gianfranco Catalano, Serena Travaglini

|Apr 15, 2022
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITD<sup>mut</sup> AML.

Serena Travaglini, Tiziana Ottone, Daniela Francesca Angelini

|Apr 30, 2021
Sexually Dimorphic Immune and Neuroimmune Changes Following Peripheral Nerve Injury in Mice: Novel Insights for Gender Medicine.

Valentina Vacca, Sara Marinelli, Federica De Angelis

Pageof 2

Frequent Collaborators

5 joint publications

Luca Battistini

4 joint publications

Maria Teresa Voso

2 joint publications

Serena Travaglini

2 joint publications

Adriano Venditti